logo

MRNA

Moderna·NASDAQ
--
--(--)
--
--(--)

MRNA fundamentals

Moderna (MRNA) expects to report earnings on Feb 13, 2026, with estimated revenue of 635.15M (YoY -34.25%), and EPS at -2.5445 (YoY +12.56%).
Revenue estimate / YoY
635.15M
-34.25%
EPS estimate / YoY
-2.5445
+12.56%
Report date
Feb 13, 2026
Earnings Call
8:00 AM on Feb 13, 2026
Meeting link.
EPS
Revenue

Revenue & Expenses

MRNA has released its 2025 Q3 earnings report, with revenue of 1.02B, reflecting a YoY change of -45.44%, and net profit of -200.00M, showing a YoY change of -1638.46%. The Sankey diagram below clearly presents MRNA's revenue sources and cost distribution.

Key Indicators

Moderna (MRNA) key financial stats and ratios, covering profitability, financial health, and leverage.
Moderna (MRNA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Moderna (MRNA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Moderna (MRNA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Moderna (MRNA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Moderna (MRNA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield